🇺🇸 FDA
Pipeline program

Ramelteon SL

TAK-375SL_201

Phase 3 small_molecule terminated

Quick answer

Ramelteon SL for Acute Depressive Episode is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Acute Depressive Episode
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials